{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:36Z","timestamp":1786988076490,"version":"build-2736575974"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ50635"],"award-info":[{"award-number":["2026JJ50635"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Sichuan Province Health Commission","doi-asserted-by":"publisher","award":["24QNMP009"],"award-info":[{"award-number":["24QNMP009"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejmech.2026.118842","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:12:16Z","timestamp":1775315536000},"page":"118842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting WRN helicase in MSI-H tumors: Synthetic lethality, small molecule discovery, and therapeutic perspectives"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6325-1516","authenticated-orcid":false,"given":"Chunlan","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118842_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218183","article-title":"Overcoming radioresistance in prostate cancer by targeting DNA damage repair","volume":"639","author":"Matos","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118842_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41573-025-01212-6","article-title":"Targeting DNA damage in ageing: towards supercharging DNA repair","volume":"24","author":"Bujarrabal-Dueso","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib4","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","article-title":"Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118842_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e15036","article-title":"Development of a DNA damage response (DDR) therapeutics platform for oncology","volume":"39","author":"Das","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118842_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41568-021-00386-6","article-title":"Targeting the DNA damage response in immuno-oncology: developments and opportunities","volume":"21","author":"Chabanon","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118842_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218210","article-title":"lncDDR suppresses drug resistance by regulating DNA damage repair through ILF2-YB1 in T-cell acute lymphoblastic leukemia","volume":"639","author":"Zhu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-022-02469-0","article-title":"The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy","volume":"41","author":"Shi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib9","article-title":"Human RecQ helicases in DNA double-strand break repair","volume":"9","author":"Lu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev-biochem-060713-035428","article-title":"Human RecQ helicases in DNA repair, recombination, and replication","volume":"83","author":"Croteau","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.118842_bib11","first-page":"393","article-title":"The RecQ DNA helicases in DNA repair","volume":"44","author":"Bernstein","year":"2010","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf426","article-title":"During recombinase-mediated homology recognition RecQ helicases inhibit formation of toxic long-lived D-loops that could promote genomic instability","volume":"53","author":"Danilowicz","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc2682","article-title":"RecQ helicases: multifunctional genome caretakers","volume":"9","author":"Chu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118842_bib14","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.3390\/ijms19113442","article-title":"Werner syndrome protein and DNA replication","volume":"19","author":"Mukherjee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118842_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/nar\/gkac1200","article-title":"Werner syndrome protein works as a dimer for unwinding and replication fork regression","volume":"51","author":"Shin","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib16","first-page":"42","article-title":"Targeted inhibition of WRN helicase, replication stress and cancer","volume":"1867","author":"Orlovetskie","year":"2017","journal-title":"BBA - Rev. Cancer."},{"key":"10.1016\/j.ejmech.2026.118842_bib17","article-title":"PARP inhibitors plough on","volume":"16","author":"Mullard","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib18","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1021\/acs.jmedchem.4c00113","article-title":"New Horizons of synthetic lethality in cancer: current development and future perspectives","volume":"67","author":"Previtali","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41586-020-2769-8","article-title":"Repeat expansions confer WRN dependence in microsatellite-unstable cancers","volume":"586","author":"van Wietmarschen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118842_bib20","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.12025","article-title":"Monitoring microsatellite instability (MSI) in circulating tumor DNA by next-generation DNA-seq","volume":"36","author":"Deng","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118842_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/2159-8290.CD-20-1508","article-title":"Werner helicase is a synthetic-lethal vulnerability in mismatch repair\u2013deficient colorectal cancer refractory to targeted therapies, chemotherapy, and immunotherapy","volume":"11","author":"Picco","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117022","article-title":"Targeting werner helicase: a novel combination strategy for MSI colorectal cancer","volume":"239","author":"Peng","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118842_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2026.2619753","article-title":"The Werner syndrome RECQ helicase as a therapeutic target: new insights","volume":"30","author":"Sidorova","year":"2026","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2026.118842_bib24","doi-asserted-by":"crossref","first-page":"13218","DOI":"10.1021\/acs.jmedchem.5c01114","article-title":"WRN as a novel target of synthetic lethality: current advances and future perspectives","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108771","article-title":"Targeting WRN helicase: discovery and development of its selective inhibitors","volume":"163","author":"Deng","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib26","article-title":"Challenges for the discovery of non-covalent WRN helicase inhibitors","volume":"19","author":"Heuser","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.118842_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng0897-335","article-title":"Impaired nuclear localization of defective DNA helicases in Werner's syndrome","volume":"16","author":"Matsumoto","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2026.118842_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10522-008-9205-z","article-title":"Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging","volume":"10","author":"Singh","year":"2009","journal-title":"Biogerontology"},{"key":"10.1016\/j.ejmech.2026.118842_bib29","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.dnarep.2008.07.017","article-title":"Roles of the Werner syndrome RecQ helicase in DNA replication","volume":"7","author":"Sidorova","year":"2008","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2026.118842_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10522-014-9506-3","article-title":"Acetylation of Werner syndrome protein (WRN): relationships with DNA damage, DNA replication and DNA metabolic activities","volume":"15","author":"Lozada","year":"2014","journal-title":"Biogerontology"},{"key":"10.1016\/j.ejmech.2026.118842_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.201410061","article-title":"BLM helicase facilitates telomere replication during leading strand synthesis of telomeres","volume":"210","author":"Drosopoulos","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib32","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.M116.767699","article-title":"Residues in the RecQ C-terminal domain of the human Werner syndrome helicase are involved in unwinding G-quadruplex DNA","volume":"292","author":"Ketkar","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2023.11.541","article-title":"Regulation of DNA end resection by the Werner syndrome helicase","volume":"123","author":"Mawn","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2026.118842_bib34","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000795","article-title":"Structure of the helicase core of werner helicase, a key target in microsatellite instability cancers","volume":"4","author":"Newman","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ejmech.2026.118842_bib35","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/nar\/29.13.2843","article-title":"The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases","volume":"29","author":"Mohaghegh","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib36","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-18-1877","article-title":"HERC2 facilitates BLM and WRN helicase complex interaction with RPA to suppress G-Quadruplex DNA","volume":"78","author":"Wu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nsmb1088","article-title":"WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing","volume":"13","author":"Perry","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib38","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/nar\/28.17.3260","article-title":"Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA","volume":"28","author":"Shen","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib39","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.3390\/ijms25158300","article-title":"Response to replication stress and maintenance of genome stability by WRN, the Werner syndrome protein","volume":"25","author":"Orren","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118842_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0047-6374(01)00248-2","article-title":"Unwinding the molecular basis of the Werner syndrome","volume":"122","author":"Shen","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2026.118842_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41467-025-55958-z","article-title":"Phosphorylation-dependent WRN-RPA interaction promotes recovery of stalled forks at secondary DNA structure","volume":"16","author":"Noto","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118842_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mad.2004.06.004","article-title":"The Werner syndrome protein at the crossroads of DNA repair and apoptosis","volume":"125","author":"Comai","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2026.118842_bib43","article-title":"Single-molecule studies reveal reciprocating of WRN helicase core along ssDNA during DNA unwinding","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118842_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13785","article-title":"WRN regulates pathway choice between classical and alternative non-homologous end joining","volume":"7","author":"Shamanna","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118842_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","article-title":"MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118842_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117347","article-title":"Research progress in DNA damage response (DDR)-targeting modulators: from hits to clinical candidates","volume":"287","author":"Cheng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.isci.2019.02.006","article-title":"Werner syndrome helicase is required for the survival of cancer cells with microsatellite instability","volume":"13","author":"Kategaya","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.118842_bib48","article-title":"Microsatellite instability causes repeat expansion and WRN dependence","volume":"10","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib49","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.onc.1206169","article-title":"Werner's syndrome protein is phosphorylated in an ATR\/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle","volume":"22","author":"Pichierri","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.118842_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13484","article-title":"CDK2 phosphorylation of werner protein (WRN) contributes to WRN's DNA double-strand break repair pathway choice","volume":"20","author":"Lee","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejmech.2026.118842_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2024.100051","article-title":"PLK1 phosphorylates WRN at replication forks","volume":"392","author":"Wang","year":"2025","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118842_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","article-title":"Cellular functions of the protein kinase ATM and their relevance to human disease","volume":"22","author":"Lee","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12880","article-title":"CDK1 phosphorylates WRN at collapsed replication forks","volume":"7","author":"Palermo","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118842_bib54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41594-022-00881-w","article-title":"Human DNA-dependent protein kinase activation mechanism","volume":"30","author":"Liang","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108287","article-title":"The 9-1-1 complex controls Mre11 nuclease and checkpoint activation during short-range resection of DNA double-strand breaks","volume":"33","author":"Gobbini","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118842_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001918","article-title":"Acetylation regulates WRN catalytic activities and affects base excision DNA repair","volume":"3","author":"Muftuoglu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118842_bib57","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1074\/jbc.M709707200","article-title":"Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib58","article-title":"Werner syndrome protein (WRN) regulates cell proliferation and the human papillomavirus 16 life cycle during epithelial differentiation","volume":"5","author":"James Claire","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2026.118842_bib59","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1093\/nar\/gkae807","article-title":"Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks","volume":"52","author":"Palermo","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46358-7","article-title":"PARP1 regulates DNA damage-induced nucleolar-nucleoplasmic shuttling of WRN and XRCC1 in a toxicant and protein-specific manner","volume":"9","author":"Veith","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118842_bib61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.mad.2005.06.004","article-title":"Cellular dynamics and modulation of WRN protein is DNA damage specific","volume":"126","author":"Karmakar","year":"2005","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2026.118842_bib62","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/jgs.14906","article-title":"Recent trends in WRN gene mutation patterns in individuals with Werner syndrome","volume":"65","author":"Yamaga","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ejmech.2026.118842_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","article-title":"Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions","volume":"33","author":"Oshima","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118842_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41698-022-00319-y","article-title":"Clinical prospects of WRN inhibition as a treatment for MSI tumours","volume":"6","author":"Morales-Juarez","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.ejmech.2026.118842_bib65","article-title":"CRISPR screens single out WRN","volume":"9","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib66","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11523-025-01183-z","article-title":"Targeting DNA damage repair pathways beyond PARP inhibition","volume":"20","author":"Merry","year":"2025","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.ejmech.2026.118842_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114450","article-title":"Pharmacological targeting of differential DNA repair, radio-sensitizes WRN-deficient cancer cells in vitro and in vivo","volume":"186","author":"Gupta","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118842_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10238-025-01781-1","article-title":"Targeting the Werner syndrome protein in microsatellite instability cancers: mechanisms and therapeutic potential","volume":"25","author":"Chen","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2026.118842_bib69","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/0008-5472.CAN-10-1066","article-title":"BCR\/ABL stimulates WRN to promote survival and genomic instability","volume":"71","author":"Slupianek","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib70","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/biom15101370","article-title":"Traditional and new views on MSI-H\/dMMR endometrial cancer","volume":"15","author":"Liu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118842_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13402-011-0024-x","article-title":"Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications","volume":"34","author":"Zaanan","year":"2011","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejmech.2026.118842_bib72","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1111\/bph.15422","article-title":"Nuclear translocation of ATG5 induces DNA mismatch repair deficiency (MMR-D)\/microsatellite instability (MSI) via interacting with Mis18\u03b1 in colorectal cancer","volume":"178","author":"Sun","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118842_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/cells11030521","article-title":"CNOT6: a novel regulator of DNA mismatch repair","volume":"11","author":"Song","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.118842_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2015.11.408","article-title":"Single-molecule studies on EXOI excision during DNA mismatch repair","volume":"110","author":"Jeon","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2026.118842_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118842_bib76","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1210\/jc.2017-02332","article-title":"Reduced expression of mismatch repair genes MSH6\/MSH2 directly promotes pituitary tumor growth via the ATR\u2013Chk1 pathway","volume":"103","author":"Uraki","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.118842_bib77","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.celrep.2014.10.025","article-title":"Nonenzymatic role for WRN in preserving nascent DNA strands after replication stress","volume":"9","author":"Su","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118842_bib78","doi-asserted-by":"crossref","first-page":"23236","DOI":"10.1074\/jbc.M111446200","article-title":"Biochemical characterization of the DNA substrate specificity of Werner syndrome helicase","volume":"277","author":"Brosh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib79","article-title":"WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures","volume":"42","author":"Mengoli","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.118842_bib80","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers","volume":"568","author":"Chan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118842_bib81","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1021\/acs.jmedchem.4c01909","article-title":"Structural chemistry of helicase inhibition","volume":"68","author":"Selvaratnam","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib82","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1073\/pnas.1006423108","article-title":"Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress","volume":"108","author":"Aggarwal","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118842_bib83","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.4161\/cc.26320","article-title":"Targeting an achilles' heel of cancer with a WRN helicase inhibitor","volume":"12","author":"Aggarwal","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2026.118842_bib84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2012.10.016","article-title":"A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells","volume":"20","author":"Nguyen","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118842_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2015.01.014","article-title":"Acute cytotoxicity of MIRA-1\/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis","volume":"359","author":"Bou-Hanna","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129711","article-title":"Targeting ATP-binding site of WRN helicase: identification of novel inhibitors through pocket analysis and molecular dynamics-enhanced virtual screening","volume":"104","author":"Yuan","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210525","article-title":"A high-throughput screen to identify novel small molecule inhibitors of the Werner syndrome helicase-nuclease (WRN)","volume":"14","author":"Sommers","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118842_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117588","article-title":"Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability","volume":"100","author":"Yang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117660","article-title":"Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives","volume":"102","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107963","article-title":"Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability","volume":"153","author":"Yu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib91","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11030-024-10844-6","article-title":"Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents","volume":"29","author":"Li","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.118842_bib92","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-024-07350-y","article-title":"Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers","volume":"629","author":"Ferretti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118842_bib93","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/1535-7163.MCT-25-0666","article-title":"Microsatellite instable cancer cells acquire On-target resistance mutations to WRN helicase inhibitors","volume":"25","author":"Fowler","year":"2026","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.118842_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130141","article-title":"Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers","volume":"120","author":"Moon","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117039","article-title":"Design, synthesis, and structure\u2212activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors","volume":"282","author":"Sui","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib96","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1021\/acs.jmedchem.4c03029","article-title":"Validation, key pharmacophores, and X-ray cocrystal structures of novel biochemically and cellularly active WRN inhibitors derived from a DNA-encoded library screen","volume":"68","author":"Tong","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib97","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-5750","article-title":"Abstract 5750: discovery of GSK4418959 (IDE275): a novel, non-covalent, reversible werner helicase inhibitor and a new potential therapeutic for the treatment of MSI-H cancers","volume":"85","author":"Taygerly","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib98","article-title":"Abstract 1755: discovery of a novel, selective WRN inhibitor, DAT-5000A, in the treatment of microsatellite-unstable tumors","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib99","article-title":"Abstract LB187: YF087 is a potent and selective inhibitor of WRN, specifically targeting MSI-H cancer cells","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib100","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-2894","article-title":"Abstract 2894: NTX-452: a non-covalent, potent, selective and highly efficacious WRN inhibitor with best-in-class potential for the treatment of MSI-H tumors","volume":"85","author":"Svensson","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib101","article-title":"Abstract 4192: preclinical characterization of LAE122, a novel, potent and selective WRN inhibitor for the treatment of MSI-H tumors","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118842_bib102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1021\/acsmedchemlett.5c00216","article-title":"Novel spirocyclic WRN helicase inhibitors for treating cancer","volume":"16","author":"Sabnis","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118842_bib103","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/acs.biochem.2c00599","article-title":"Identification of 2-Sulfonyl\/Sulfonamide pyrimidines as covalent inhibitors of WRN using a multiplexed high-throughput screening assay","volume":"62","author":"Parker","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118842_bib104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-024-07318-y","article-title":"Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase","volume":"629","author":"Baltgalvis","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118842_bib105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/2159-8290.CD-24-0052","article-title":"Novel WRN helicase inhibitors selectively target microsatellite-unstable cancer cells","volume":"14","author":"Picco","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/jacs.3c10581","article-title":"Using a function-first \u201cscout fragment\u201d-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes","volume":"146","author":"Ramsey","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118842_bib107","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41557-019-0351-5","article-title":"Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs","volume":"11","author":"Wang","year":"2019","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib108","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1021\/acs.jmedchem.4c01308","article-title":"Covalent inhibitors: to infinity and beyond","volume":"67","author":"Raouf","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib109","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/acs.jmedchem.4c02760","article-title":"Covalent-allosteric inhibitors: do we get the best of both worlds?","volume":"68","author":"Tao","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118842_bib111","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.1096361","article-title":"The many roles of computation in drug discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118842_bib112","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","article-title":"Fragment-based lead discovery","volume":"3","author":"Rees","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib113","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17460441.2021.1832079","article-title":"Approaches to mitigate the risk of serious adverse reactions in covalent drug design","volume":"16","author":"Baillie","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib115","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/acs.jcim.8b00104","article-title":"Modeling small-molecule reactivity identifies promiscuous bioactive compounds","volume":"58","author":"Matlock","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118842_bib116","first-page":"1","article-title":"Understanding drug-target residence time and the implications on drug discovery","volume":"21","author":"Liu","year":"2026","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib117","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/jacs.8b11747","article-title":"Chemistry for covalent modification of endogenous\/native proteins: from test tubes to complex biological systems","volume":"141","author":"Tamura","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118842_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71160-5","article-title":"PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability","volume":"14","author":"Tejwani","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118842_bib119","doi-asserted-by":"crossref","first-page":"15477","DOI":"10.1021\/acs.jmedchem.1c01532","article-title":"Development of BromoTag: a \u201cBump-and-Hole\u201d\u2013PROTAC system to induce potent, rapid, and selective degradation of tagged target proteins","volume":"64","author":"Bond","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118842_bib120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43333","article-title":"Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells","volume":"8","author":"Lieb","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.118842_bib121","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib122","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118842_bib123","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.coph.2020.09.011","article-title":"RNAi therapeutics: an antiviral strategy for human infections","volume":"54","author":"Kelleher","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118842_bib124","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13625","article-title":"Non-enzymatic function of WRN RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-\u03baB signaling in cancer","volume":"21","author":"Gupta","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejmech.2026.118842_bib125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1101\/gad.351085.123","article-title":"Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR","volume":"37","author":"Zong","year":"2023","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2026.118842_bib126","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/emboj.2010.205","article-title":"ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery","volume":"29","author":"Ammazzalorso","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.118842_bib127","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.dnarep.2008.08.008","article-title":"WRN protects against topo I but not topo II inhibitors by preventing DNA break formation","volume":"7","author":"Christmann","year":"2008","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2026.118842_bib128","first-page":"7136","article-title":"Werner protein stimulates topoisomerase I DNA relaxation activity","volume":"63","author":"Laine","year":"2003","journal-title":"Cancer Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:45:29Z","timestamp":1781271929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":128,"alternative-id":["S0223523426002874"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118842","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting WRN helicase in MSI-H tumors: Synthetic lethality, small molecule discovery, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118842"}}